Abeona Therapeutics Inc (ABEO) Stock: Navigating Market Highs and Lows in 52 Weeks

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Abeona Therapeutics Inc’s current trading price is 4.38% away from its 52-week high, while its distance from the 52-week low is 183.11%. The stock’s price range for this period has been between $2.19 and $5.94 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 231.59 for the day, a number notably higher than the average daily volume of 3.59 over the last three months.

Abeona Therapeutics Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $5.94 on 02/09/24, while the lowest price for the same duration was marked at $2.19 on 02/24/23.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Abeona Therapeutics Inc (ABEO) has experienced a quarterly rise of 45.54% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 153.57M.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 4.54, with a change in price of +2.53. Similarly, Abeona Therapeutics Inc recorded 192,438 in trading volume during the last 100 days, posting a change of +68.94%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ABEO stands at 0.26. Similarly, the long-term debt-to-equity ratio is also 0.18.

ABEO Stock Stochastic Average

As of today, Abeona Therapeutics Inc’s raw stochastic average for the last 50 days stands at 94.36%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 94.36%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 79.10% and 53.18%, respectively.

ABEO Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price gain of 23.75% this year. Over the last six months, there has been a weaker performance of 107.36%. The price of ABEO fallen by 15.03% during the last 30 days period. For the last 5-days stocks have improved 40.27%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts